Esophagus · 2016 · 257 citations · 0 references
MedicineOncologySurgeryGastrointestinal OncologyOncologic SurgerySurgical OncologyConcurrent ChemoradiationEsophageal CancerEsophageal DiseasesEsophageal SurgeryRadiation TherapySquamous Cell CarcinomaAdenocarcinoma Of The EsophagusClinical Survival RatesEndoscopic Surgical ResectionIn-hospital MortalityOperative MorbiditySquamous Cell Carcinoma HistologySurvival RatesThoracoscopic Esophageal Surgery
9 %, middle thoracic: 48.0 %, lower thoracic: 27.7 % and EG junction: 6.6 %. Superficial carcinomas (Tis, T1a, T1b) were 36.7 %. As for the histologic type of biopsy specimens, squamous cell carcinoma and adenocarcinoma accounted for 90.5 and 3.8 %, respectively. Regarding clinical results, the 5-year survival rates of patients treated using endoscopic mucosal resection, concurrent chemoradiotherapy, radiotherapy alone, chemotherapy alone, or esophagectomy were 86.2, 27.9, 20.2, 5.8, and 55.9 %, respectively. Esophagectomy was performed in 3844 cases. Concerning the approach used for esophagectomy, 24.9 % of the cases were treated thoracoscopically. The operative mortality (within 30 days after surgery) was 1.01 % and the hospital mortality was 4.76 %.